Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...

CVS Health’s second quarter results surpassed Wall Street’s expectations, with management attributing the outperformance ...

CVS Health reported an impressive adjusted operating income of $3.8 billion and an adjusted EPS of $1.81. The company has also increased its full-year 2025 adjusted EPS guidance to a range of $6.30 to ...

Investors responded with optimism following CVS Health’s CVS second-quarter 2025 earnings release last week, buoyed by better ...

CVS Health CVS reported its second-quarter 2025 results last week, wherein adjusted operating income (AOI) rose 2% year over year to approximately $3.80 billion. This was supported by 39.4% AOI growth ...

CVS Health (NYSE: CVS) reported that strong performance from Signify Health (NYSE: SGFY), the company’s home-focused platform, relieved pressure in other ...

CVS Health posted strong second-quarter results and raised its full-year guidance following strong performances in its Aetna and pharmacy segments, but its healthcare delivery segment remains under ...

Healthcare costs presented a significant financial challenge for CVS in the second quarter, company leaders said Thursday.

Shares of CVS Health jumped on Thursday after the healthcare giant posted better-than-expected second-quarter results and raised its 2025 forecast. | CVS Health raised its 2025 forecast based on ...

CVS Health topped Wall Street expectations for the second quarter and hiked its full-year forecast again, as the health care giant continued to rally under new management from a forgettable 2024 ...